Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Samsara is digitizing the world of physical operations.
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
DOBT.net is a community-based, digital asset trading platform .
A materials technology company.
True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.
Advizr creats financial planning software that enables profitable financial planning for all of its customers.
Franklin Templeton has invested in 222 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Franklin Templeton's top investment sectors include SaaS, Software, Biotechnology, Health Care, Business Intelligence. The firm invests across 20 different industry categories.
Among tracked funding rounds, Ionic Materials received $65.0M in a Series C round. Franklin Templeton's total known invested capital is $29.6B.
Franklin Templeton's average investment size is $130.2M across its portfolio of 222 companies.
Recent Franklin Templeton portfolio additions include Samsara. These companies were founded in 2020 or later.